financetom
Business
financetom
/
Business
/
OnMobile promoter sells part stake at Rs 75-80 per share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OnMobile promoter sells part stake at Rs 75-80 per share
Sep 17, 2019 2:28 AM

OnMobile Global promoters sold 19 million shares of the company to Jump Networks at a price of more than Rs 75 per share, almost double than the current market price of the stock at below Rs 40. Explaining the price, OnMobile Global CFO Ganesh Murthy said the company has always believed that the stock has been significantly undervalued.

"If you look at our financials last year, year ending March 2019, we had a revenue of Rs 594 crore and end of June, we had a cash balance of Rs 251 crore. We have no debt in the company. So a total of about Rs 800 plus one time revenue is about Rs 845 crore and we have 105 million shares outstanding. So that roughly gives you a value of about Rs 80 per share. The current transaction is near that,” he noted.

Murthy said the promoter currently holds 48 percent of the company, which will be reduced to 30 percent following the sale.

“Our board remains as before. There is no commitment or discussion regarding their board seat to Jump Networks. We believe that there is a lot of synergy between Jump Networks and OnMobile. The plan is to leverage their customer base, which can be pretty large and offer services that OnMobile traditionally provides through the telecom operators,” said Murthy.

“The reason for the revenue decline over the last couple of years - Ring Back Tones which is our flagship product has been declining in many of the mature markets even in India. However, we have taken steps to launch products, which are related to mobile entertainment, like mobile gaming. That is our growth area in the future. We expect a significant growth. Our plan is to significantly invest in these areas and grow the business in mobile gaming,” he further mentioned.

“Our aim is to complete the year with around 10 percent EBITDA margins in the following years and that is the result of investments that we are making in the mobile gaming area,” Murthy said.

“For the next five years, we are looking at something like about Rs 300-400 crore coming out of gaming itself,” he added.

When asked why the promoter is selling, he replied, “Those are the reasons which we have to ask the promoter. The company is not aware of those reasons, why he is selling. He has been promoter for many years now in the company, so I think this is a partial liquidation of his stake and partial encashment of profits.”

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-SLB Announces Agreement To Acquire ChampionX In An All-Stock Transaction
BRIEF-SLB Announces Agreement To Acquire ChampionX In An All-Stock Transaction
Apr 2, 2024
April 2 (Reuters) - SLB: * SLB ANNOUNCES AGREEMENT TO ACQUIRE CHAMPIONX IN AN ALL-STOCK TRANSACTION * SLB ANNOUNCES AGREEMENT TO ACQUIRE CHAMPIONX IN AN ALL-STOCK TRANSACTION * SLB - CHAMPIONX SHAREHOLDERS TO RECEIVE 0.735 SLB SHARES FOR EACH SHARE OF CHAMPIONX * SLB: CHAMPIONX SHAREHOLDERS TO RECEIVE 0.735 SLB SHARES FOR EACH SHARE OF CHAMPIONX * SLB - SLB...
UL Solutions' Sole Stockholder to Offer 28 Million Shares in IPO
UL Solutions' Sole Stockholder to Offer 28 Million Shares in IPO
Apr 2, 2024
10:47 AM EDT, 04/02/2024 (MT Newswires) -- UL Solutions (ULS) said in a regulatory filing Tuesday that its sole shareholder, ULSE, plans to sell 28 million shares in an initial public offering priced at $26 to $29 per share. The selling stockholder has provided a 30-day option to underwriters to buy up to a further of 4.2 million shares, UL...
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test
QuidelOrtho Gets US FDA Clearance For QuickVue COVID-19 Test
Apr 2, 2024
10:58 AM EDT, 04/02/2024 (MT Newswires) -- QuidelOrtho ( QDEL ) said Tuesday that its QuickVue COVID-19 test has received 510(k) clearance from the US Food and Drug Administration. The clearance allows the test to be used in home and medical facility settings with CLIA certificates of waiver, the company said. QuidelOrtho ( QDEL ) shares were down more than...
Update: Acorda Therapeutics Shares Fall Amid $185 Million Asset Sale Deal, Chapter 11 Proceedings
Update: Acorda Therapeutics Shares Fall Amid $185 Million Asset Sale Deal, Chapter 11 Proceedings
Apr 2, 2024
11:00 AM EDT, 04/02/2024 (MT Newswires) -- (Updates to include Acorda's recent stock movement in the headline and the first paragraph.) Acorda Therapeutics ( ACOR ) shares fell more than 79% in recent Tuesday trading after saying it has signed an agreement to sell substantially all its assets to Merz Therapeutics for $185 million. The company said late Monday that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved